key: cord-0916599-c5nzkd17 authors: Aiken, A. R. A.; Starling, J. E.; Gomperts, R.; Scott, J. G.; Aiken, C. title: Demand for Self-Managed Online Telemedicine Abortion in Eight European Countries During the COVID-19 Pandemic: A Regression Discontinuity Analysis date: 2020-09-18 journal: nan DOI: 10.1101/2020.09.15.20195222 sha: 435f6785cd339fd60a5e7c60595babe5df7511ef doc_id: 916599 cord_uid: c5nzkd17 Objectives: In most European countries, patients seeking medication abortion during the COVID-19 pandemic are still expected to attend healthcare settings in person despite lockdown measures and infection risk. We assessed whether demand for self-managed medication abortion provided by a fully remote online telemedicine service increased following the emergence of COVID-19. Design: We used regression discontinuity to compare the number of requests to online telemedicine service Women on Web in eight European countries before and after they implemented lockdown measures to slow COVID-19 transmission. We examined the number deaths due to COVID-19, the degree of government-provided economic support, the severity of lockdown travel restrictions, and the medication abortion service provision model in countries with and without significant changes in requests. Setting: Eight European countries served by Women on Web. Participants: 3,915 people who made requests for self-managed abortion to Women on Web between January 1st, 2019 and June 1st, 2020. Main Outcome Measures: Percent change in requests to Women on Web before and after the emergence of COVID-19 and associated lockdown measures. Results: Five countries showed significant increases in requests, ranging from 28% in Northern Ireland (p=0.001) to 139% in Portugal (p<0.001). Two countries showed no significant change in requests, and one country, Great Britain, showed an 88% decrease in requests (p<0.001). Countries with significant increases in requests were either countries where abortion services are mainly provided in hospitals or where no abortion services are available and international travel was prohibited during lockdown. By contrast, Great Britain authorized teleconsultation for medication abortion and provision of medications by mail during the pandemic. Conclusion: These marked changes in requests for self-managed medication abortion during COVID-19 demonstrate demand for fully remote models of abortion care and an urgent need for policymakers to expand access to medication abortion by telemedicine. The first wave of the COVID-19 pandemic posed challenges for the provision of abortion care 59 in Europe. Reallocation of resources, redeployment of staff, and social distancing requirements 60 all introduced new barriers to in-person clinic visits. 1,2 61 5 online telemedicine abortion changed in eight European countries after stay-at-home restrictions 83 to slow the spread of COVID-19 were introduced. Among those countries that WoW does serve, some have only a few consultations requests over 102 the course of a year. We excluded countries that had too few requests to reliable detect 103 differences in request numbers between the 'before' and 'after' periods (i.e. fewer than 10 104 expected requests in the 'after' period). We also excluded Spain, because the Spanish 105 Government censored the WoW website during the study period and so no requests could be 106 made, 13 and Poland because the number of requests made to WoW has been unstable since the 107 beginning of 2020. 108 6 109 We obtained the daily number of requests made to WoW from the eight countries in our sample 110 between 1 st January 2019 and 1 st June 2020 (the last day that lockdown measures were lifted in a 111 country included in the analysis). We excluded duplicate requests, which were identified as >1 112 request with the same information and location made within 12 hours. The number of requests 113 from each country was analysed using a regression-discontinuity design. 14 We designated a 114 'before' period, which began on 1 st January 2019 and ended on the date that each individual 115 country's government issued their first 'stay-at-home' directive. The one exception was 116 Germany, where the 'before' period begins on 1 st January 2020, due to the fact that WoW did 117 not accept consultations from Germany in until late 2019. The 'after' period began the first day 118 after the 'stay-at-home' directive was issued for each country, and ended on the first day that the 119 directives were eased in each country. 'Stay-at-home' directives were chosen as the threshold date 120 defining the "pre" and "post" periods, because the majority of European countries issued such a 121 directive, which posed definitive limitations on population movement and activities. Of the 122 countries included in our analytic sample, only Malta did not issue a population-wide directive, 123 and we instead used the date that the Maltese government issued a directive to close public 124 places as the discontinuity point. 15 125 126 We fit a generalised linear model (GLM) for each country's daily requests between 1 st January 127 2019 ( 1 st January 2020, for Germany) and the date of easing 'stay-at-home' restrictions. The 128 model incorporated a dummy variable for the 'before' v. 'after' period, representing a possible 129 discontinuity at the day of the 'stay-at-home' directive. The significance of the discontinuity for 130 each country was assessed using a likelihood ratio test to compare with a null model that did not 131 include a dummy variable for the 'before' v. 'after' period. The null model was also used to 132 generate Monte Carlo simulations for each country, which create a probability distribution of the 133 expected requests in the 'after' period with no discontinuity. The observed requests line would 134 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. . 7 be highly likely to lie within this probability distribution if there was no difference in requests 135 between the 'before' and 'after' periods. We also calculated the percentage difference between 136 observed and expected requests in the 'after' period. For Northern Ireland, both the null and 137 discontinuity models also included a dummy variable indicating the period after 10 th April 2020, 138 because abortion services became available for the first time in Northern Ireland on this date. 16 139 140 We also compiled information for each country included in the analysis on several metrics we 141 hypothesised could be related to demand for online abortion: stringency of 'stay-at-home' 142 requirements; deaths due to COVID-19; economic assistance provided by governments in 143 response to the pandemic; 17 and abortion service provision before and during the pandemic. 7,18-20 144 We examined each of these metrics across each country included in the analysis to assess their 145 relationship to changes in requests to WoW. 146 147 Data analyses were conducted using the R statistical package version 3.6.2. 21 Findings were 148 considered statistically significant at an alpha level of 0.05. The study was reviewed by the 149 University of Texas at Austin Institutional Review Board and considered exempt on the basis 150 that the study is an analysis of pre-collected, fully de-identified data. 151 152 Patients were not involved in the design or conduct of the study. However, the follow-up that 154 WoW provides is designed to address the priorities and experiences of people who access the 155 service. Thus, although this study is an analysis of secondary, de-identified data, with no direct 156 participant involvement, the research questions were informed by the needs of people who rely 157 on WoW to access abortion. 158 159 160 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. . https://doi.org/10.1101/2020.09.15.20195222 doi: medRxiv preprint During the data collection period, Women on Web received 3,915 requests for abortion 162 medications from the eight countries included in the analysis. Among these, we observed a 163 statistically significant increase in requests during the 'after' period in five countries: Hungary, 164 Italy, Malta, Portugal, and Northern Ireland (Figure 1 ). The magnitude of the observed increases 165 ranged from 139% above expected in Portugal to 28% above expected in Northern Ireland 166 (Table 1 ). In two countries (Germany, the Netherlands) there was no statistically significant 167 difference in observed compared to expected numbers of requests in the 'after' period ( Figure 1 168 and Table 1 ). In one country (Great Britain), there was a statistically significant decrease in 169 requests in the 'after' period ( Figure 1 and Table 1 ). 170 Countries that had higher numbers of COVID-19 related deaths or which provided less 172 government economic support during the pandemic did not appear to have higher numbers of 173 requests to WoW (Table 2) . We did however, observe a relationship between higher numbers of 174 requests and both the location of abortion service provision, and the severity of domestic and 175 international travel restrictions (Table 2 ). In Italy, Portugal, and Hungary, all of which showed 176 significant increases in requests to WoW, abortion is provided mostly in the hospital setting and 177 all enacted stringent stay-at-home requirements. In Northern Ireland and Malta, where 178 significant increases in requests were also observed, in-clinic abortion services are only available 179 by traveling outside of the country, and international travel was restricted during the study 180 periods. In Germany and the Netherlands, we observed no increases in requests, abortion 181 services remained available in clinic settings, and no country-wide domestic travel restrictions 182 were enacted. In Great Britain, abortion services were made available by fully remote 183 telemedicine shortly after lockdown began and we observed a significant decrease in requests. 184 185 186 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. Our data provide a unique window into requests for self-managed medication abortion using 203 online telemedicine during COVID-19. Key strengths include the ability to measure changes in 204 demand for self-managed abortion from a reliable source that does not rely on self-reporting, 205 and the ability to compare data from before and after the emergence of COVID-19. An 206 important limitation, however, is that there are of course other pathways to abortion outside the 207 formal healthcare setting in Europe, including alternative sources of mifepristone and 208 misoprostol, and non-medication methods. Thus, we cannot measure all demand for self-209 managed abortion during the pandemic. We also lack nuanced insight into the exact reasons 210 underlying changes in requests to WoW for any particular country. It is important to note that in 211 the two countries where we observed no increases in requests, people likely still encountered 212 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. . https://doi.org/10.1101/2020.09.15.20195222 doi: medRxiv preprint These challenges to accessing medication abortion during COVID-19, coupled with the 239 increases we observed in requests for online telemedicine are reflected in the fact that people in 240 countries where the challenges are greatest found their own solutions outside the clinic setting. 241 However, while medication abortion provided via online telemedicine is a safe and effective 242 option, 10,11 it is not without legal risks. 26 Its safety also depends on access to the formal healthcare 243 system when necessary, which is not guaranteed during a pandemic. Additionally, while some 244 people may prefer self-managed medication abortion, others may experience it as fraught and 245 isolating due to stigma or the threat of criminalization, or may have preferred in-clinic care. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The Corresponding Author has the right to grant on behalf of all authors and does grant on be-292 half of all authors, a worldwide licence to the Publishers and its licensees in perpetuity, in all 293 forms, formats and media (whether known now or created in the future), to i) publish, repro-294 duce, distribute, display and store the Contribution, ii) translate the Contribution into other lan-295 guages, create adaptations, reprints, include within collections and create summaries, extracts 296 and/or, abstracts of the Contribution, iii) create any other derivative work(s) based on the Con-297 tribution, iv) to exploit all subsidiary rights in the Contribution, v) the inclusion of electronic 298 links from the Contribution to third party material where-ever it may be located; and, vi) licence 299 any third party to do any or all of the above. 300 301 Data Sharing 302 No additional data are available. 303 All authors, external and internal, had full access to all of the data (including statistical reports 304 and tables) in the study and can take responsibility for the integrity of the data and the accuracy 305 of the data analysis. Ethics Approval 308 The University of Texas at Austin Institutional Review Board reviewed the study protocol and 309 declared the use of pre-collected, fully de-identified data exempt from the need for approval. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. . Transparency 314 ARAA affirms that the manuscript is an honest, accurate, and transparent account of the study 315 being reported; that no important aspects of the study have been omitted; and that any 316 discrepancies from the study as planned (and, if relevant, registered) have been explained 317 318 Role of the Funding Source 319 This study was supported in part by the Eunice Kennedy Shriver National Institute of Child 320 Health & Human Development of the NIH through Center Grant P2CHD042849, awarded to 321 the Population Research Center at the University of Texas at Austin. The funder played no role 322 in the study design; in the collection, analysis, and interpretation of data; in the writing of the 323 report; or in the decision to submit the article for publication. The authors are completely 324 independent from the funding sources. The content of this article is solely the responsibility of 325 the authors and does not necessarily represent the official views of the National Institutes of 326 Health. Dissemination Declaration 329 We plan to disseminate the results to people who have made requests to the WoW service by 330 having a link to the published paper included in the 'Research' section of the WoW website. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. . for times of pandemic. Sexual and Reproductive Health Matters. 2020 Jan 1;28(1):1779633. 460 461 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. . Medication abortion provision changed from in-person to fully remote service model, including phone consultation and pills provided by mail or pick-up at a clinic † Malta did not issue a population-wide directive, so that date that the Maltese government issued 470 a directive to close public places is used in lieu. 471 472 473 474 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. Cumulative requests in the "before" versus "after" periods are in black and orange, respectively. 477 Vertical dashed lines show the dates when stay-at-home orders were announced. The blue line 478 shows the model without any discontinuities (the null model), and the green line shows the 479 model fit with a discontinuity. for the stay-at-home order. The pink lines are the 250 Monte 480 Carlo simulations from the null model, which support the likelihood ratio test's finding that the 481 model with discontinuities is a significantly better fit than the null model. 482 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted September 18, 2020. . https://doi.org/10.1101/2020.09.15.20195222 doi: medRxiv preprint Safe abortion amid the COVID-19 pandemic: The case of Italy Caruana-Finkel L. Abortion in the time of COVID-19: perspectives from Malta R: A language and environment for statistical computing. R Foundation 422 for Statistical Computing Coronavirus Created an Obstacle 426 Course for Safe Abortions